Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (BDX)
NYSE:BDX
Holding BDX?
Track your performance easily
BDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$218.75 - $249.89
Previous Close$225.48
Volume366.60K
Average Volume (3M)1.37M
Market Cap
$64.65B
Enterprise Value$79.19B
Total Cash (Recent Filing)$5.31B
Total Debt (Recent Filing)$19.32B
Price to Earnings (P/E)38.0
Beta0.46
Next Earnings
Feb 06, 2025EPS Estimate
$2.98Next Dividend Ex-Date
Dec 09, 2024Dividend Yield1.7%
Share Statistics
EPS (TTM)5.94
Shares Outstanding289,042,418
10 Day Avg. Volume2,067,819
30 Day Avg. Volume1,374,178
Standard Deviation0.06
R-Squared0.16
Alpha-0.00401
Financial Highlights & Ratios
Price to Book (P/B)2.48
Price to Sales (P/S)3.25
Price to Cash Flow (P/CF)12.40
P/FCF Ratio14.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.04
Enterprise Value/Gross Profit9.69
Enterprise Value/Ebitda17.32
Forecast
1Y Price Target
$277.00Price Target Upside23.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Becton Dickinson News
PremiumCompany Announcements
Becton, Dickinson Reports Strong Fiscal 2024 Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBDX finished F24 with F4Q organic revenue growth of 6.2%, op margin expansion of 120 bps and EPS up 11.4% from last year.
Market PositionBD is expected to benefit from this huge shift, as it is the global market leader for prefilled syringes.
Product DevelopmentBDX has an attractive multi-product pipeline with several key launches planned for the next calendar year.
Bears Say
Competitive LandscapeWith the Chinese Government putting emphasis on domestic medical device and drug manufacturers, BD may be at a disadvantage.
Financial GuidanceBDX introduced FY25 guidance of +4.0-4.5% organic growth, which is behind expectations of 5.8% and 5.2%.
Market PerformanceBDX expects sales in China to be down at least mid-single digits in FY25.
---
Ownership Overview
0.12% Insiders
23.90% Mutual Funds
22.96% Other Institutional Investors
32.10% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Macro & PoliticalRisks related to catastrophic events or geopolitical conditions that may disrupt the company’s business
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BDX FAQ
What was Becton Dickinson And Company’s price range in the past 12 months?
Becton Dickinson And Company lowest stock price was $218.75 and its highest was $249.89 in the past 12 months.
What is Becton Dickinson And Company’s market cap?
Currently, no data Available
When is Becton Dickinson And Company’s upcoming earnings report date?
Becton Dickinson And Company’s upcoming earnings report date is Feb 06, 2025 which is in 72 days.
How were Becton Dickinson And Company’s earnings last quarter?
Becton Dickinson And Company released its earnings results on Nov 07, 2024. The company reported $3.81 earnings per share for the quarter, beating the consensus estimate of $3.768 by $0.042.
Is Becton Dickinson And Company overvalued?
According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued.
Does Becton Dickinson And Company pay dividends?
Becton Dickinson And Company pays a Quarterly dividend of $1.04 which represents an annual dividend yield of 1.7%. See more information on Becton Dickinson And Company dividends here
What is Becton Dickinson And Company’s EPS estimate?
Becton Dickinson And Company’s EPS estimate is $2.98.
How many shares outstanding does Becton Dickinson And Company have?
Becton Dickinson And Company has 289,042,420 shares outstanding.
What happened to Becton Dickinson And Company’s price movement after its last earnings report?
Becton Dickinson And Company reported an EPS of $3.81 in its last earnings report, beating expectations of $3.768. Following the earnings report the stock price went down -5.394%.
Which hedge fund is a major shareholder of Becton Dickinson And Company?
Among the largest hedge funds holding Becton Dickinson And Company’s share is Generation Investment Management LLP. It holds Becton Dickinson And Company’s shares valued at 1B.
---
Becton Dickinson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$277.00 (23.85% Upside)
$277.00 (23.85% Upside)
Blogger Sentiment
Bullish
BDX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 917.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 7.7%
Last 30 Days ▲ 7.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.07%
12-Months-Change
Fundamentals
Return on Equity
6.68%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Becton Dickinson And Company
Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.
---
BDX Company Deck
---
BDX Earnings Call
Q4 2024
0:00 / 0:00
---
BDX Revenue Breakdown
22.16% Medication Delivery Solutions
18.71% Integrated Diagnostic Solutions
15.38% Medication Management Solutions
11.51% Pharmaceutical Systems
32.24% Other
---
BDX Stock 12 Month Forecast
Average Price Target
$277.00
▲(23.85% Upside)
Technical Analysis
Best Analysts Covering BDX
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+4.65%
reiterated a buy rating 8 months ago
Copying David Toung's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +4.65% per trade.
---